Targeting the brain: considerations in 332 consecutive patients treated by deep brain stimulation (DBS) for severe neurological diseases.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 22271259)

Published in Neurol Sci on January 24, 2012

Authors

Angelo Franzini1, Roberto Cordella, Giuseppe Messina, Carlo Efisio Marras, Luigi Michele Romito, Alberto Albanese, Michele Rizzi, Nardo Nardocci, Giovanna Zorzi, Edvin Zekaj, Flavio Villani, Massimo Leone, Orsola Gambini, Giovanni Broggi

Author Affiliations

1: Fondazione IRCCS Istituto Neurologico "C. Besta", Via Celoria 11, 20133, Milan, Italy.

Associated clinical trials:

Thalamic Deep Brain Stimulation for Secondary Dystonia in Children and Young Adults (DBSVop) | NCT03078816

Articles cited by this

(truncated to the top 100)

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry (1992) 33.67

Deep brain stimulation for treatment-resistant depression. Neuron (2005) 12.39

Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry (1999) 7.87

Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med (2003) 6.59

Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain (2005) 4.33

Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease. Lancet Neurol (2009) 4.22

Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain (2007) 4.13

Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry (2000) 4.03

Neuroimaging studies of mood disorders. Biol Psychiatry (2000) 3.92

Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet (1991) 3.89

Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. Neuroreport (2005) 3.80

Hypothalamic activation in cluster headache attacks. Lancet (1998) 3.32

Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage (2004) 3.15

Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol (1987) 3.14

Translational principles of deep brain stimulation. Nat Rev Neurosci (2007) 3.10

Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg (1992) 3.01

Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord (1999) 2.98

Classification of dystonia. Adv Neurol (1998) 2.75

Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: Outcomes after one year. Clin Neurol Neurosurg (2009) 2.57

Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain (2000) 2.25

Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry (2005) 2.08

The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. J Chem Neuroanat (2003) 2.08

Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain (2006) 2.07

Unilateral pedunculopontine stimulation improves falls in Parkinson's disease. Brain (2009) 2.05

Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry (2007) 2.03

Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg (2006) 2.02

Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease. Neuroreport (2005) 2.01

Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J Neurosurg (2003) 2.01

Pain-related neurons in the human cingulate cortex. Nat Neurosci (1999) 1.92

Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain (2009) 1.91

Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet (1999) 1.79

The pathophysiology of tremor. Muscle Nerve (2001) 1.76

Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg (1994) 1.66

Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain (2010) 1.66

Hypothalamic stimulation in chronic cluster headache: a pilot study of efficacy and mode of action. Brain (2005) 1.57

Deep brain stimulation for Parkinson's disease. Neurotherapeutics (2008) 1.53

Postero-medial hypothalamotomy in the treatment of aggressive behaviors. Confin Neurol (1966) 1.51

Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry (1999) 1.49

Stereotactic stimulation of posterior hypothalamic gray matter in a patient with intractable cluster headache. N Engl J Med (2001) 1.49

Treatment of parkinsonism by stereotatic thermolesions in the pallidal region. A clinical evaluation of 81 cases. Acta Psychiatr Scand (1960) 1.47

The concepts of the ventral striatopallidal system and extended amygdala. Ann N Y Acad Sci (1999) 1.43

Neuromodulation of the cingulum for neuropathic pain after spinal cord injury. Case report. J Neurosurg (2007) 1.42

A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats. Brain Res (1989) 1.42

Stimulation of the posterior hypothalamus for treatment of chronic intractable cluster headaches: first reported series. Neurosurgery (2003) 1.41

[Effects of the stimulation of the subthalamic nucleus in Parkinson disease]. Rev Neurol (Paris) (1993) 1.39

Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. J Neurosurg (2003) 1.39

Physiological observations in stereotaxic operations in extrapyramidal motor disturbances. Brain (1960) 1.38

High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol (1997) 1.36

Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor. Mov Disord (2001) 1.36

Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery (1994) 1.35

Long-term outcome of 50 consecutive Parkinson's disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat Disord (2007) 1.33

Electrophysiology of the hippocampal and amygdaloid projections to the nucleus accumbens of the rat: convergence, segregation, and interaction of inputs. J Neurosci (1998) 1.32

Some certainty for the "zone of uncertainty"? Exploring the function of the zona incerta. Neuroscience (2005) 1.31

Modulation of basolateral amygdala neuronal firing and afferent drive by dopamine receptor activation in vivo. J Neurosci (1999) 1.29

Electrical stimulation of the hippocampal epileptic foci for seizure control: a double-blind, long-term follow-up study. Epilepsia (2007) 1.21

Treatment of DYT1-generalised dystonia by stimulation of the internal globus pallidus. Lancet (2000) 1.19

Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome. Report of three cases. J Neurosurg (2003) 1.16

Stimulation of the globus pallidus internus for childhood-onset dystonia. Mov Disord (2005) 1.13

Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. Neurology (2002) 1.13

Bilateral stimulation of the caudal zona incerta nucleus for tremor control. J Neurol Neurosurg Psychiatry (2007) 1.12

Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson's disease tremor. Neurology (1998) 1.11

Deep brain stimulation for intractable pain: a 15-year experience. Neurosurgery (1997) 1.11

Specific hypothalamic activation during a spontaneous cluster headache attack. Neurology (2004) 1.10

The neuronal organization of the supracapsular part of the stria terminalis in the rat: the dorsal component of the extended amygdala. Neuroscience (1998) 1.10

The posterior hypothalamic area: chemoarchitecture and afferent connections. Brain Res (2001) 1.09

Long-lasting insomnia induced by preoptic neuron lesions and its transient reversal by muscimol injection into the posterior hypothalamus in the cat. Neuroscience (1989) 1.08

Deep brain stimulation between 1947 and 1987: the untold story. Neurosurg Focus (2010) 1.07

Deep brain stimulation of the nucleus ventralis intermedius for Holmes (rubral) tremor and associated dystonia caused by upper brainstem lesions. Report of two cases. J Neurosurg (2004) 1.06

Stereotactic localization of the human pedunculopontine nucleus: atlas-based coordinates and validation of a magnetic resonance imaging protocol for direct localization. Brain (2008) 1.06

Bilateral stimulation of globus pallidus internus for treatment of cervical dystonia. Lancet (1999) 1.06

Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation. Mov Disord (2009) 1.05

Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trial. Mov Disord (2008) 1.03

Electrical stimulation of the brain in treatment of chronic pain. Experience over 5 years. J Neurosurg (1985) 1.02

Long-term effects of bilateral subthalamic nucleus stimulation in advanced Parkinson disease: a four year follow-up study. Parkinsonism Relat Disord (2005) 1.02

Treatment of chronic pain by deep brain stimulation: long term follow-up and review of the literature. Neurosurgery (1987) 1.02

Results of stimulation and destruction of the posterior hypothalamus in man. J Neurosurg (1970) 1.01

Ventralis intermedius plus ventralis oralis anterior and posterior deep brain stimulation for posttraumatic Holmes tremor: two leads may be better than one: technical note. Neurosurgery (2005) 1.01

Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia. J Neural Transm Gen Sect (1993) 1.00

Center median-parafascicular complex and pain control. Review from a neurosurgical perspective. Stereotact Funct Neurosurg (2004) 1.00

Unilateral subthalamotomy in the treatment of Parkinson's disease. Brain (2003) 1.00

Thalamic deep brain stimulation for the treatment of head, voice, and bilateral limb tremor. J Neurosurg (1999) 0.99

ELECTRICAL SELF-STIMULATION OF THE BRAIN IN MAN. Am J Psychiatry (1963) 0.98

A case of posttraumatic tremor treated by chronic stimulation of the thalamus. Mov Disord (1993) 0.98

Reversal of thalamic hand syndrome by long-term motor cortex stimulation. J Neurosurg (2000) 0.97

Electrical stimulation of the centromedian thalamic nucleus in control of seizures: long-term studies. Epilepsia (1995) 0.97

Afferent connections of the zona incerta: a horseradish peroxidase study in the rat. Neuroscience (1985) 0.96

Enkephalin-like material elevated in ventricular cerebrospinal fluid of pain patients after analgetic focal stimulation. Science (1978) 0.95

Two-year follow-up of chronic stimulation of the posterior subthalamic white matter for tremor-dominant Parkinson's disease. Neurosurgery (2005) 0.92

Reversibility of chronic neurologic deficits. Some effects of electrical stimulation of the thalamus and internal capsule in man. Appl Neurophysiol (1980) 0.92

Improvement of levodopa induced dyskinesias by thalamic deep brain stimulation is related to slight variation in electrode placement: possible involvement of the centre median and parafascicularis complex. J Neurol Neurosurg Psychiatry (1999) 0.92

Deep-brain stimulation of the nucleus accumbens in obsessive compulsive disorder: clinical, surgical and electrophysiological considerations in two consecutive patients. Neurol Sci (2010) 0.91

Deep brain stimulation of the posteromedial hypothalamus: indications, long-term results, and neurophysiological considerations. Neurosurg Focus (2010) 0.91

The role of descending basal ganglia connections to the brain stem in parkinsonian akinesia. Br J Neurosurg (1998) 0.91

Electrical stimulation of the prelemniscal radiation in the treatment of Parkinson's disease: an old target revised with new techniques. Neurosurgery (2001) 0.91

Deep brain stimulation for treatment of the epilepsies: the centromedian thalamic target. Acta Neurochir Suppl (2007) 0.91

The neurons of the substantia nigra and zona incerta which project to the cat superior colliculus are GABA immunoreactive: a double-label study using GABA immunocytochemistry and lectin retrograde transport. Neuroscience (1989) 0.91

Thalamotomy versus thalamic stimulation for multiple sclerosis tremor. J Clin Neurosci (2005) 0.90

Improvement of severe postural cerebellar tremor in multiple sclerosis by chronic thalamic stimulation. Mov Disord (1996) 0.90

Stereotaxic interventions on the zona incerta area for treatment of extrapyramidal motor disturbances and their results. Confin Neurol (1965) 0.90

Deep brain stimulation electrode used for radiofrequency lesion of the globus pallidus internus in dystonia. Stereotact Funct Neurosurg (2009) 0.90

Articles by these authors

Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science (2004) 15.91

Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med (2004) 4.56

Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA. Am J Hum Genet (2012) 3.80

PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet (2006) 2.97

Levodopa in the treatment of Parkinson's disease: current controversies. Mov Disord (2004) 2.90

The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol (2013) 2.65

β-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation. Brain (2013) 2.40

Spontaneous intracranial hypotension syndrome: a novel speculative physiopathological hypothesis and a novel patch method in a series of 28 consecutive patients. J Neurosurg (2010) 2.38

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease. N Engl J Med (2016) 2.36

Transportin-SR2 imports HIV into the nucleus. Curr Biol (2008) 2.35

PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol (2004) 2.30

Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord (2010) 2.20

Deep Brain Stimulation in Gilles de la Tourette Syndrome: What Does the Future Hold? A Cohort of 48 Patients. Neurosurgery (2016) 2.07

Diagnostic value of endomyocardial biopsy guided by electroanatomic voltage mapping in arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Cardiovasc Electrophysiol (2008) 1.98

Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol (2008) 1.96

Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Ann Neurol (2006) 1.86

Red flags for multiple system atrophy. Mov Disord (2008) 1.75

Is fluorescein-guided technique able to help in resection of high-grade gliomas? Neurosurg Focus (2014) 1.74

Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians. Eur J Hum Genet (2005) 1.71

PARK6-linked parkinsonism occurs in several European families. Ann Neurol (2002) 1.68

Surgical site infections after elective neurosurgery: a survey of 1747 patients. Neurosurgery (2008) 1.66

Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain (2010) 1.66

Effectiveness of higher doses of botulinum toxin to induce healing in patients with chronic anal fissures. Surgery (2002) 1.65

Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis. Lancet Neurol (2011) 1.62

Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol (2007) 1.59

Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology (2009) 1.56

Image-guided endoscopic transnasal removal of recurrent pituitary adenomas. Neurosurgery (2002) 1.55

A novel impermeable adhesive membrane to reinforce dural closure: a preliminary retrospective study on 119 consecutive high-risk patients. World Neurosurg (2011) 1.53

The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohort. Dev Med Child Neurol (2011) 1.53

Respiratory failure in infants due to spinal muscular atrophy with respiratory distress type 1. Intensive Care Med (2006) 1.53

Progressive supranuclear palsy and Parkinson's disease in a family with a new mutation in the tau gene. Ann Neurol (2004) 1.51

Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann Neurol (2002) 1.51

A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene. Arch Neurol (2003) 1.49

Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myeloma. Haematologica (2002) 1.49

Pathological gambling in Parkinson's disease: subthalamic oscillations during economics decisions. Mov Disord (2013) 1.45

Stimulation of the posterior hypothalamus for treatment of chronic intractable cluster headaches: first reported series. Neurosurgery (2003) 1.41

Pallidotomy for medically refractory status dystonicus in childhood. Dev Med Child Neurol (2014) 1.40

Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation. Lancet Neurol (2012) 1.39

Imatinib mesylate in T-cell large granular lymphocyte leukemia associated with chronic graft-versus-host disease. Leuk Lymphoma (2011) 1.39

Paroxysmal non-epileptic motor events in childhood: a clinical and video-EEG-polymyographic study. Dev Med Child Neurol (2012) 1.39

Neuromodulation of chronic headaches: position statement from the European Headache Federation. J Headache Pain (2013) 1.39

The role of indocyanine green videoangiography (ICGV) in surgery of parasagittal meningiomas. Acta Neurochir (Wien) (2013) 1.38

Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord (2010) 1.34

Fluorescein-guided surgery for grade IV gliomas with a dedicated filter on the surgical microscope: preliminary results in 12 cases. Acta Neurochir (Wien) (2013) 1.34

Intracavitary VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma. J Neurooncol (2003) 1.30

Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease. Mov Disord (2002) 1.28

Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon (2013) 1.27

Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model. Neuron (2008) 1.26

Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urology (2003) 1.23

Presurgical functional MR imaging of language and motor functions: validation with intraoperative electrocortical mapping. Radiology (2008) 1.23

CD133 is essential for glioblastoma stem cell maintenance. Stem Cells (2013) 1.21

Iron-related MRI images in patients with pantothenate kinase-associated neurodegeneration (PKAN) treated with deferiprone: results of a phase II pilot trial. Mov Disord (2011) 1.21

Hypothalamic stimulation for intractable cluster headache: long-term experience. Neurology (2006) 1.19

Orbitofrontal dysfunction and medication overuse in patients with migraine. Headache (2012) 1.19

Meningiomas invading the superior sagittal sinus: surgical experience in 108 cases. Neurosurgery (2004) 1.19

Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival. Clin Cancer Res (2007) 1.19

Myoclonus-dystonia syndrome: clinical presentation, disease course, and genetic features in 11 families. Mov Disord (2008) 1.15

Metabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutations. Mol Genet Metab (2011) 1.13

Stimulation of the globus pallidus internus for childhood-onset dystonia. Mov Disord (2005) 1.13

Health-related quality of life in multiple system atrophy. Mov Disord (2006) 1.11

Mutation screening of the DYT6/THAP1 gene in Italy. Mov Disord (2009) 1.11

Dendrimer internalization and intracellular trafficking in living cells. Mol Pharm (2010) 1.11

Hypothalamic deep brain stimulation in positron emission tomography. J Neurosci (2006) 1.10

The diagnostic challenge of primary dystonia: evidence from misdiagnosis. Mov Disord (2010) 1.10

Dural sinus thrombosis in spontaneous intracranial hypotension: Hypotheses on possible mechanisms. J Neurol (2006) 1.09

Periventricular nodular heterotopia: classification, epileptic history, and genesis of epileptic discharges. Epilepsia (2006) 1.08

Pearls and pitfalls: neurostimulation in headache. Cephalalgia (2013) 1.07

Genetic alterations and in vivo tumorigenicity of neurospheres derived from an adult glioblastoma. Mol Cancer (2004) 1.06

A neurophysiological study of myoclonus in patients with DYT11 myoclonus-dystonia syndrome. Mov Disord (2008) 1.06

Validation of the Italian version of the Movement Disorder Society--Unified Parkinson's Disease Rating Scale. Neurol Sci (2012) 1.06

Neuritis ossificans. J Neurosurg (2014) 1.06

Endoscopic third ventriculostomy in idiopathic normal pressure hydrocephalus: an Italian multicenter study. Neurosurgery (2008) 1.06

PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum. Hum Mutat (2008) 1.06

Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Mov Disord (2009) 1.06

Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation. Mov Disord (2009) 1.05

Sphenopalatine endoscopic ganglion block: a revision of a traditional technique for cluster headache. Laryngoscope (2006) 1.01

Synergistic control of protein kinase Cgamma activity by ionotropic and metabotropic glutamate receptor inputs in hippocampal neurons. J Neurosci (2006) 1.01

Deep brain stimulation to relieve drug-resistant SUNCT. Ann Neurol (2005) 1.01

Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association. J Neurol (2012) 0.99

Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome. Toxicon (2012) 0.98

Inclusion and exclusion criteria for DBS in dystonia. Mov Disord (2011) 0.97

Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study). Arch Neurol (2011) 0.97

Substantia nigra in Parkinson's disease: a multimodal MRI comparison between early and advanced stages of the disease. Neurol Sci (2013) 0.97

Microvascular decompression for glossopharyngeal neuralgia: a long-term retrospectic review of the Milan-Bologna experience in 31 consecutive cases. Acta Neurochir (Wien) (2009) 0.97